Literature DB >> 20354143

The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling.

Sandra Pastorino1, Hemamalini Renganathan, Maisel J Caliva, Erin L Filbert, John Opoku-Ansah, Florian J Sulzmaier, Joanna E Gawecka, Guy Werlen, Andrey S Shaw, Joe W Ramos.   

Abstract

PEA-15 is a death effector domain-containing phosphoprotein that binds ERK and restricts it to the cytoplasm. PEA-15 also binds to FADD and thereby blocks apoptosis induced by death receptors. Abnormal expression of PEA-15 is associated with type II diabetes and some cancers; however, its physiological function remains unclear. To determine the function of PEA-15 in vivo, we used C57BL/6 mice in which the PEA-15 coding region was deleted. We thereby found that PEA-15 regulates T-cell proliferation. PEA-15-null mice did not have altered thymic or splenic lymphocyte cellularity or differentiation. However, PEA-15 deficient T cells had increased CD3/CD28-induced nuclear translocation of ERK and increased activation of IL-2 transcription and secretion in comparison to control wild-type littermates. Indeed, activation of the T-cell receptor in wild-type mice caused PEA-15 release of ERK. In contrast, overexpression of PEA-15 in Jurkat T cells blocked nuclear translocation of ERK and IL-2 transcription. Finally, PEA-15-null T cells showed increased IL-2 dependent proliferation on stimulation. No differences in T cell susceptibility to apoptosis were found. Thus, PEA-15 is a novel player in T-cell homeostasis. As such this work may have far reaching implications in understanding how the immune response is controlled.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354143      PMCID: PMC2909277          DOI: 10.1096/fj.09-144295

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  42 in total

Review 1.  MAP kinases in the immune response.

Authors:  Chen Dong; Roger J Davis; Richard A Flavell
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  The Ras/MAPK cascade and the control of positive selection.

Authors:  José Alberola-Ila; Gabriela Hernández-Hoyos
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

Review 3.  Positive and negative selection of T cells.

Authors:  Timothy K Starr; Stephen C Jameson; Kristin A Hogquist
Journal:  Annu Rev Immunol       Date:  2002-10-16       Impact factor: 28.527

4.  Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling.

Authors:  Mark A Daniels; Emma Teixeiro; Jason Gill; Barbara Hausmann; Dominique Roubaty; Kaisa Holmberg; Guy Werlen; Georg A Holländer; Nicholas R J Gascoigne; Ed Palmer
Journal:  Nature       Date:  2006-11-01       Impact factor: 49.962

5.  ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.

Authors:  Hema Vaidyanathan; John Opoku-Ansah; Sandra Pastorino; Hema Renganathan; Michelle L Matter; Joe W Ramos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

6.  Dynamics of proximal signaling events after TCR/CD8-mediated induction of proliferation or apoptosis in mature CD8+ T cells.

Authors:  Xiaoqian Wang; Luca Simeoni; Jonathan A Lindquist; Julio Saez-Rodriguez; Andreas Ambach; Ernst D Gilles; Stefanie Kliche; Burkhart Schraven
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

7.  ERK1-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis.

Authors:  Anshu Agrawal; Stephanie Dillon; Timothy L Denning; Bali Pulendran
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

8.  TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways.

Authors:  Irena Stefanová; Bernhard Hemmer; Marco Vergelli; Roland Martin; William E Biddison; Ronald N Germain
Journal:  Nat Immunol       Date:  2003-02-10       Impact factor: 25.606

Review 9.  Death effector domain-containing proteins.

Authors:  M Gudur Valmiki; J W Ramos
Journal:  Cell Mol Life Sci       Date:  2009-03       Impact factor: 9.261

10.  Molecular interpretation of ERK signal duration by immediate early gene products.

Authors:  Leon O Murphy; Sallie Smith; Rey-Huei Chen; Diane C Fingar; John Blenis
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

View more
  15 in total

1.  A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells.

Authors:  Irene Hunter; Keith S Mascall; Joe W Ramos; Graeme F Nixon
Journal:  Cardiovasc Res       Date:  2011-02-01       Impact factor: 10.787

2.  Noncanonical mode of ERK action controls alternative αβ and γδ T cell lineage fates.

Authors:  Sang-Yun Lee; Francis Coffey; Shawn P Fahl; Suraj Peri; Michele Rhodes; Kathy Q Cai; Michael Carleton; Stephen M Hedrick; Hans Joerg Fehling; Juan Carlos Zúñiga-Pflücker; Dietmar J Kappes; David L Wiest
Journal:  Immunity       Date:  2014-11-28       Impact factor: 31.745

3.  Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter.

Authors:  Florian Sulzmaier; John Opoku-Ansah; Joe W Ramos
Journal:  Small GTPases       Date:  2012-06-14

4.  Circadian expression and functional characterization of PEA-15 within the mouse suprachiasmatic nucleus.

Authors:  Kelin Wheaton; Sydney Aten; Lucas Sales Queiroz; Kyle Sullivan; John Oberdick; Kari R Hoyt; Karl Obrietan
Journal:  Eur J Neurosci       Date:  2018-02-19       Impact factor: 3.386

Review 5.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

6.  PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D.

Authors:  F J Sulzmaier; M K G Valmiki; D A Nelson; M J Caliva; D Geerts; M L Matter; E P White; J W Ramos
Journal:  Oncogene       Date:  2011-11-21       Impact factor: 9.867

7.  Absence of the Adaptor Protein PEA-15 Is Associated with Altered Pattern of Th Cytokines Production by Activated CD4+ T Lymphocytes In Vitro, and Defective Red Blood Cell Alloimmune Response In Vivo.

Authors:  Stéphane Kerbrat; Benoit Vingert; Marie-Pierre Junier; Flavia Castellano; François Renault-Mihara; Silvina Dos Reis Tavares; Mathieu Surenaud; France Noizat-Pirenne; Jorge Boczkowski; Georges Guellaën; Hervé Chneiweiss; Sabine Le Gouvello
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

8.  Brief alcohol exposure alters transcription in astrocytes via the heat shock pathway.

Authors:  Leonardo Pignataro; Florence P Varodayan; Lindsay E Tannenholz; Petr Protiva; Neil L Harrison
Journal:  Brain Behav       Date:  2013-02-06       Impact factor: 2.708

Review 9.  On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities.

Authors:  Yufeng Wei
Journal:  Pharmaceuticals (Basel)       Date:  2015-07-31

Review 10.  Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states.

Authors:  Fiona H Greig; Graeme F Nixon
Journal:  Pharmacol Ther       Date:  2014-03-20       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.